Hair Growth Treatment
Last week I had the opportunity to join a video conference with the HCell team to discuss their therapy aimed at multiple forms of alopecia. The HCell company emerged on the internet around mid January 2018 through the announcement of their Orphan Drug Designation from the FDA to treat pediatric alopecia areata. That press release…
Rophe Pharma submitted a press release this week announcing its topical hair growth drug has shown positive results for restoring eyebrows. Rophe’s hair growth candidate RPHE-7193 is a topical form of the FDA approved blood pressure drug hydralazine. The drug apparently has a similar mechanism to minoxidil. Here’s a quote from the press release which…
I’ve had a few readers asking about updates lately which tells me that not everyone is aware of the new Updates thread. It is a post that acts as a Newsfeed. I use it to add quick news items and links to articles. These are for news items that do not necessitate an entire published…
Brickell Biotech, a dermatology-focused pharmaceutical company, is developing a therapy which should prove to be of interest to the online hair community. The company is based in Boulder, CO and has a variety of clinical programs underway in the area of dermatology. One such program is an oral CRTH2 antagonist for hair loss. A “CRTH2…
Located within the biotech cluster which is Cambridge, Massachusetts sits a contemporary R&D platform, the LEO Science & Tech Hub. The Science & Tech Hub is an innovation unit of the international dermatology-focused LEO Pharma company. The Tech Hub seeks to engage with and bolster new technology which may offer solutions to dermatological and other…
It was recently announced that Rophe Pharma will enter the hair growth market with a repurposed drug candidate. Robert Gadimian, CEO of Rophe Pharma, has put out a press release this month pertaining to the development of his hair growth compound RPHE-7193. See below for text of press release. “Rophe Pharma, announces it has applied…
I’ve had many readers inquire lately about the current progress of RiverTown Therapeutics Inc.’s RT1640. RTI’s therapy for hair regeneration, RT1640, is a topical medication composed of minoxidil, cyclosporine A, and a novel molecule called RT175. The company debuted some impressive hair growth photos on this site last year. The question that’s been on a…
Just when we thought we knew of every company in the world working on hair growth treatments… With all of the scientific articles on hair biology that continually get published from Asian establishments there was bound to be a few companies springing up at some point. I’m happy to say I’ve got 4 new companies…
Hello Everyone, Welcome to a new edition of Weekly Thoughts. I’ve got some details to share on how things are going at HairClone these days, as well as notions on two promising studies on genes involved in hair growth. One of the studies has had the internet ablaze lately with KROX talk. It’s surely a…
Hello Everyone, It is good to be back for another Weekly Thoughts. This edition is headlined by an anti-aging technology from The Netherlands that has shown interesting regenerative effects on mice. I even got some exclusive info on the potential of this technology to be applied to hair growth to share with you. Also, we…